Certified by Founder
Lodge
Ginossar Ventures
start up
United States
- New York City, NY
- 28/06/2024
- Unknown
- $13,000,000
Ginossar Ventures partners with forward-thinking leaders who are positioning their companies to gain traction, be ready to scale, and achieve sustainable, long-term success.
We focus on early stage B2B SaaS companies with applications in fintech, cyber security, and digital health.
- Industry Venture Capital and Private Equity Principals
- Website https://ginossarventures.com/
- LinkedIn https://www.linkedin.com/company/ginossar-ventures/
Corgi | $108,000,000 | (Jan 9, 2026)
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
Vizgen | $48,000,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Carna Health | $8,000,000 | (Jan 9, 2026)
Valinor(US) | $54,000,000 | (Jan 9, 2026)
Alveus Therapeutics Inc | $160,000,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
EpiBiologics | $107,000,000 | (Jan 9, 2026)
SpangleAI | $15,000,000 | (Jan 9, 2026)
Presto Phoenix, Inc. | $10,000,000 | (Jan 9, 2026)